Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Metastatic × Other neoplasm × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 40 Other neoplasm 1 Gastrointestinal 1

Conditions

Precancerous Conditions 211 Lymphoma 47 Leukemia 46 Multiple Myeloma 44 Leukemia, Lymphocytic, Chronic, B-Cell 42 Neoplasms, Plasma Cell 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 39 Monoclonal Gammopathy of Undetermined Significance 39 Lymphoma, Non-Hodgkin 38 Lymphoma, Mantle-Cell 37 Lymphoma, Large-Cell, Immunoblastic 37 Lymphoma, Large B-Cell, Diffuse 37 Lymphoma, Follicular 37 Myelodysplastic Syndromes 36 Burkitt Lymphoma 36 Lymphoma, B-Cell, Marginal Zone 35 Leukemia, Myeloid, Acute 35 Hodgkin Disease 35 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 34 Myeloproliferative Disorders 34 Immunoglobulin Light-chain Amyloidosis 33 Waldenstrom Macroglobulinemia 32 Immunoblastic Lymphadenopathy 32 Uterine Cervical Neoplasms 31 Lymphoma, Large-Cell, Anaplastic 31 Primary Myelofibrosis 30 Thrombocythemia, Essential 29 Leukemia, Hairy Cell 29 Leukemia, Biphenotypic, Acute 29 Uterine Cervical Dysplasia 28

Interventions

palbociclib 1 Rogaratinib 1 Fulvestrant 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04483505 2023-12-28

ROGABREAST

Fundacion CRIS de Investigación para Vencer el Cáncer

Phase 1 Completed

BreastOther neoplasm

Breast Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡